About
Bharat Biotech International Limited, a biotechnology company, engages in the research, development, and manufacture of vaccines and biotherapeutics. Its products include Revac-B+, a recombinant hepatitis-B vaccine; TYPBAR, a vi polysaccharide typhoid vaccine; BIOPOLIO, a poliomyelitis vaccine; INDIRAB, a rabies vaccine; Revac-Bmcf, a thiomersal free recombinant hepatitis-B vaccine; TEVAC, a tetanus vaccine; Scorgen, a scorpion venom anti-serum; and BioHib, a haemophilus influenza type b vaccine
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
- • 460 investors are based in Hyderabad, Telangana, India.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- biotech
- Location
- Hyderabad, India
Contact Information
Find more investors like Bharat
Search Investors